Literature DB >> 11738750

Effect of influenza immunization on CYP3A4 activity.

M S Hayney1, R J Hammes, J P Fine, J A Bianco.   

Abstract

A number of clinical reports of drug interactions with influenza vaccine have been made. We hypothesized that CYP3A4 activity would decrease following influenza immunization. Fifteen healthy subjects had erythromycin breath tests (ERMBT) and influenza antibody titer hemagglutinin inhibition assay (HIA) before and after receiving influenza vaccine. The mean age of the subjects was 31.9 years (S.D. 10.2). The change in ERMBT following influenza immunization was not significant (mean -4%, S.D. 17%, P=0.25). Influenza immunization does not significantly change CYP3A4 activity. Changes in serum drug concentrations noted previously after influenza immunization are either due to very small changes in CYP3A4 activity or other pharmacokinetic interactions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11738750     DOI: 10.1016/s0264-410x(01)00403-0

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Decreased immune responses to influenza vaccination in patients with heart failure.

Authors:  Orly Vardeny; Nancy K Sweitzer; Michelle A Detry; John M Moran; Maryl R Johnson; Mary S Hayney
Journal:  J Card Fail       Date:  2008-12-18       Impact factor: 5.712

2.  Decreased T-cell responses to influenza vaccination in patients with heart failure.

Authors:  Orly Vardeny; John J M Moran; Nancy K Sweitzer; Maryl R Johnson; Mary S Hayney
Journal:  Pharmacotherapy       Date:  2010-01       Impact factor: 4.705

3.  Immunization and Drug Metabolizing Enzymes: Focus on Hepatic Cytochrome P450 3A.

Authors:  Kristina Jonsson-Schmunk; Romi Ghose; Maria A Croyle
Journal:  Expert Rev Vaccines       Date:  2021-03-18       Impact factor: 5.217

4.  Immunological response as a source to variability in drug metabolism and transport.

Authors:  Hege Christensen; Monica Hermann
Journal:  Front Pharmacol       Date:  2012-02-10       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.